Scientists from MIT have developed an ingestible chip involving a genetically engineered probiotic E. coli strain that can monitor the gut health. By consuming this chip, a light would be generated by detecting the blood flow in the gut region. The quantity of light generated would be transmitted to a smartphone, which could easily diagnose any kind of gastrointestinal distress.
Japan's Takeda Pharmaceutical Company has signed an agreement with US-based nanotechnology provider BioSurfaces to develop new therapeutic devices to treat gastrointestinal (GI) diseases.
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.